Drugs / HP3.1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05537519 | May → Jul 2023 | urinary tract infection | Unity Health Toronto | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HP3.1 | “3-phage cocktail comprised of HP3, HP3.1 and ES19” NCT05537519 ↗ |
| Modality | Other / unclassified | “3-phage cocktail comprised of HP3, HP3.1 and ES19” NCT05537519 ↗ |
| Route | Oral | “Oral and bladder installation of bacteriophages will be administered” NCT05537519 ↗ |
| Route | Other | “Oral and bladder installation of bacteriophages will be administered” NCT05537519 ↗ |